
Anthem Biosciences Ltd. Anthem Biosciences
Anthem Biosciences
Anthem Biosciences Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
| Ex-Date | Purpose |
|---|---|
13-08-2025 | Quarterly Results |
08-11-2025 | Quarterly Results |
05-02-2026 | Quarterly Results |
19-05-2026 | Final Dividend & Audited Results |
21-07-2026 | Quarterly Results |
03-11-2026 | Quarterly Results |
News
Anthem Biosciences - Quaterly Results
Anthem Biosciences reports Profit after tax of Rs 2208.86 Mln, in the September 2026 quarter
Anthem Biosciences informs about transcript of conference call
Anthem Biosciences - Quaterly Results
Anthem Biosciences reports Profit after tax of Rs 1020.10 Mln, in the June 2026 quarter
Anthem Biosciences informs about newspaper publication
Anthem Biosciences reports Profit after tax of Rs 2116.64 Mln, in the March 2026 quarter
Anthem Biosciences - Quaterly Results
Anthem Biosciences reports Profit after tax of Rs 1121.26 Mln, in the December 2025 quarter
Anthem Biosciences informs about updates
Anthem Biosciences informs about investors meet
Anthem Biosciences reports Profit after tax of Rs 1984.34 Mln, in the September 2025 quarter
Anthem Biosciences informs about trading window closure
Anthem Biosciences trades jubilantly on reporting 65% jump in Q1 consolidated net profit
The total consolidated income of the increased by 57.25% at Rs 563.02 crore for Q1FY26
Anthem Biosciences reports 65% jump in Q1 consolidated net profit
The total consolidated income of the increased by 57.25% at Rs 563.02 crore for Q1FY26
Anthem Biosciences reports Profit after tax of Rs 148.33 Mln, in the June 2025 quarter
Anthem Biosciences - Quaterly Results
Anthem Biosciences - Quaterly Results
Anthem Biosciences lists with 27% premium on the BSE
The scrip is currently trading at Rs. 724.75, up by 154.75 points or 27.15% from its issue price
Anthem Biosciences coming with IPO to raise upto Rs 3585 crore
The issue will open for subscription on July 14, 2025 and will close on July 16, 2025
Anthem Biosciences gets SEBI’s approval to raise funds via IPO
The proposed IPO is entirely an OFS worth Rs 3,395 crore by promoters, investors and other selling shareholders
Anthem Biosciences files DRHP with SEBI for Rs 3 395 crore IPO
The proposed IPO is entirely an offer for sale (OFS) worth Rs 3,395 crore by promoters, investors and other selling shareholders